The RCI - Regensburg Center for Interventional Immunologyis recruiting a Post-doctoral Fellow in “CAR redirected T cells”
The RCI - Regensburg Center for Interventional Immunology (foundation under public law) is a novel biomedical research center focusing on translational immunology in the fields of cancer immunotherapy, transplant rejection and autoimmunity. The objective
of the RCI is to develop effective immune therapeutic strategies in these areas.
The Chair for Genetic Immunotherapy at the RCI, Prof. Dr. Hinrich Abken, is recruiting a Post-doctoral Fellow in “CAR redirected T cells” (all gender, reference number HA-2020-1) with a track record in the field of T cell immunology, with substantial experience working with recombinant immune cell receptors, in particular chimeric antigen receptors (CARs). The position is limited to two years and is remunerated on the TV-L salary scale (TV-L EG 13).
More information here